Research rockstar Matthew Disney, PhD, and team from Scripps Florida have created drug-like compounds that based on results thus far in […]
Independently-owned Columbus Ohio-based Aventiv Research was selected by the Pfizer/BioNTech “Project Lightspeed” program to participate in the Phase 2/3 clincial […]
A Maryland resident could be the first individual in the world to be vaccinated against SARS-CoV-2, the virus behind COVID-19, […]
Professor Robin Shattock and team at Imperial College London initiated an important COVID-19 vaccine clinical trial recently as they prepare […]
The U.S. Food and Drug Administration has completed its review of Moderna’s Investigational New Drug (IND) application for its SARS-CoV-2 […]
The National Institute of Neurological Disorders and Stroke, (NINDS) part of the National Institutes of Health (NIH) in recognition of […]
Moderna Inc. is a clinical-stage biotech venture pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of […]
Bradley J. Fikes of the San Diego Union Tribune reports San Diego-based Locana has raised $55 million in venture capital […]
Founded in 2016, Expansion Therapeutics (Expansion) is a drug discovery and development company pursuing the vast potential of small molecule […]
As reported by OA Online, Origenis has entered into a global license deal with Expansion Therapeutics. The two will collaborate on research […]
